220 related articles for article (PubMed ID: 23863176)
1. Regulation of Janus kinases by SOCS proteins.
Kershaw NJ; Murphy JM; Lucet IS; Nicola NA; Babon JJ
Biochem Soc Trans; 2013 Aug; 41(4):1042-7. PubMed ID: 23863176
[TBL] [Abstract][Full Text] [Related]
2. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity.
Babon JJ; Kershaw NJ; Murphy JM; Varghese LN; Laktyushin A; Young SN; Lucet IS; Norton RS; Nicola NA
Immunity; 2012 Feb; 36(2):239-50. PubMed ID: 22342841
[TBL] [Abstract][Full Text] [Related]
3. SOCS regulation of the JAK/STAT signalling pathway.
Croker BA; Kiu H; Nicholson SE
Semin Cell Dev Biol; 2008 Aug; 19(4):414-22. PubMed ID: 18708154
[TBL] [Abstract][Full Text] [Related]
4. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3.
Tamiya T; Kashiwagi I; Takahashi R; Yasukawa H; Yoshimura A
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):980-5. PubMed ID: 21508344
[TBL] [Abstract][Full Text] [Related]
5. SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.
Kershaw NJ; Murphy JM; Liau NP; Varghese LN; Laktyushin A; Whitlock EL; Lucet IS; Nicola NA; Babon JJ
Nat Struct Mol Biol; 2013 Apr; 20(4):469-76. PubMed ID: 23454976
[TBL] [Abstract][Full Text] [Related]
6. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.
Collins AS; McCoy CE; Lloyd AT; O'Farrelly C; Stevenson NJ
PLoS One; 2013; 8(7):e69090. PubMed ID: 23894411
[TBL] [Abstract][Full Text] [Related]
7. Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease.
Durham GA; Williams JJL; Nasim MT; Palmer TM
Trends Pharmacol Sci; 2019 May; 40(5):298-308. PubMed ID: 30948191
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-6 family cytokines by SOCS3.
Babon JJ; Varghese LN; Nicola NA
Semin Immunol; 2014 Feb; 26(1):13-9. PubMed ID: 24418198
[TBL] [Abstract][Full Text] [Related]
9. Understanding SOCS protein specificity.
Linossi EM; Calleja DJ; Nicholson SE
Growth Factors; 2018 Aug; 36(3-4):104-117. PubMed ID: 30318950
[TBL] [Abstract][Full Text] [Related]
10. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
11. The biology and mechanism of action of suppressor of cytokine signaling 3.
Babon JJ; Nicola NA
Growth Factors; 2012 Aug; 30(4):207-19. PubMed ID: 22574771
[TBL] [Abstract][Full Text] [Related]
12. Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.
O'Sullivan LA; Liongue C; Lewis RS; Stephenson SE; Ward AC
Mol Immunol; 2007 Apr; 44(10):2497-506. PubMed ID: 17208301
[TBL] [Abstract][Full Text] [Related]
13. Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling.
Skjesol A; Liebe T; Iliev DB; Thomassen EI; Tollersrud LG; Sobhkhez M; Lindenskov Joensen L; Secombes CJ; Jørgensen JB
Dev Comp Immunol; 2014 Jul; 45(1):177-89. PubMed ID: 24582990
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
[TBL] [Abstract][Full Text] [Related]
15. A family of cytokine-inducible inhibitors of signalling.
Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
[TBL] [Abstract][Full Text] [Related]
16. Purification of SOCS (Suppressor of Cytokine Signaling) SH2 Domains for Structural and Functional Studies.
Liau NP; Laktyushin A; Babon JJ
Methods Mol Biol; 2017; 1555():173-182. PubMed ID: 28092033
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3.
Bergamin E; Wu J; Hubbard SR
Structure; 2006 Aug; 14(8):1285-92. PubMed ID: 16905102
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
19. Formal modelling of toll like receptor 4 and JAK/STAT signalling pathways: insight into the roles of SOCS-1, interferon-β and proinflammatory cytokines in sepsis.
Paracha RZ; Ahmad J; Ali A; Hussain R; Niazi U; Tareen SH; Aslam B
PLoS One; 2014; 9(9):e108466. PubMed ID: 25255432
[TBL] [Abstract][Full Text] [Related]
20. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box.
Hanada T; Yoshida T; Kinjyo I; Minoguchi S; Yasukawa H; Kato S; Mimata H; Nomura Y; Seki Y; Kubo M; Yoshimura A
J Biol Chem; 2001 Nov; 276(44):40746-54. PubMed ID: 11522790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
